【结 构 式】 |
【分子编号】24421 【品名】(1S,5R)bicyclo[3.2.0]hept-2-en-6-one 【CA登记号】 |
【 分 子 式 】C7H8O 【 分 子 量 】108.13992 【元素组成】C 77.75% H 7.46% O 14.8% |
合成路线1
该中间体在本合成路线中的序号:(I)The reaction of bicyclo[3.2.0]hept-2-en-6-one (I) with 1,3-dibromo-5,5-dimethylhydantoin (DBDMH) in acetic acid gives 3-endo-acetoxy-2-exo-bromo-bicyclo[3.2.0]heptan-6-one (II), which is treated with morpholine in dichloromethane to yield 5-endo-acetoxy-7-anti morpholinobicyclo[2.2.l]heptan-2-one (III). Hydrolysis of (III) with NaOH gives the norbornanone (IV), which is alkylated with biphenyl methylbromide under phase transfer catalysis to give 5-endo[(1,1'-biphenyl)-4 yl]methoxy-7-anti-morpholinobicyclo[2.2.1]heptan 2-one (V). Baeyer-Villiger oxidation followed by partial reduction with diisobutylaluminum hydride (Dibal) gives the aldehyde (VI), which is then homologated to the aldehyde (VII) using methoxymethylenetriphenyl phosphorane and subsequent treatment with 2N HCl. Condensation of (VII) with 3 carboxypropyl triphenylphosphorane in tetrahydrofuran affords the acid (VIII). Finally, this compound is oxidized with Jones' reagent.
【1】 Lumley, P.; AH-23848. Drugs Fut 1986, 11, 2, 85. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 10388 | Morpholine | 110-91-8 | C4H9NO | 详情 | 详情 |
(A) | 24427 | 6-(2-[1,1'-biphenyl]-4-ylethoxy)-8-(4-morpholinyl)-2-oxabicyclo[3.2.1]octan-3-one | C25H29NO4 | 详情 | 详情 | |
(I) | 24421 | (1S,5R)bicyclo[3.2.0]hept-2-en-6-one | C7H8O | 详情 | 详情 | |
(II) | 24422 | 3-Acetoxy-2-bromobicyclo[3,2,0]hept-2-en-6-one | C8H9BrO | 详情 | 详情 | |
(III) | 24424 | 5(endo)-Acetoxy-7(R)-(4-morpholinyl)bicyclo[2,2,1]heptan-2-one | C12H19NO2 | 详情 | 详情 | |
(IV) | 24425 | 5-hydroxy-7-(4-morpholinyl)bicyclo[2.2.1]heptan-2-one | C11H17NO3 | 详情 | 详情 | |
(V) | 24426 | 5-(2-[1,1'-biphenyl]-4-ylethoxy)-7-(4-morpholinyl)bicyclo[2.2.1]heptan-2-one | C25H29NO3 | 详情 | 详情 | |
(VI) | 24428 | 2-[(1R,2R,3R,5S)-5-(2-[1,1'-biphenyl]-4-ylethoxy)-3-hydroxy-2-(4-morpholinyl)cyclopentyl]acetaldehyde | C25H31NO4 | 详情 | 详情 | |
(VII) | 24429 | 3-[(1R,2R,3R,5S)-5-(2-[1,1'-biphenyl]-4-ylethoxy)-3-hydroxy-2-(4-morpholinyl)cyclopentyl]propanal | C26H33NO4 | 详情 | 详情 | |
(VIII) | 24431 | (E)-6-[(1R,2R,3R,5S)-5-(2-[1,1'-biphenyl]-4-ylethoxy)-3-hydroxy-2-(4-morpholinyl)cyclopentyl]-3-hexenoic acid | C29H37NO5 | 详情 | 详情 | |
(C) | 24430 | 3-Carboxypropyltriphenylphosphonium bromide | C22H23BrO2P | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I), (II)Resolution of bicyclo[3.2.0]hept-2-en-6-one (I) via the R-(+)-alpha-methylbenzylamine-bisulfite (A) addition complex provides the 1S-(-)-enantiomer (II), which affords the 3-endo-acetoxy-2-exo-bromobicyclo[3.2.0]heptan-6-one (III) on treatment with 1,3-dibromo-5,5-dimethylhydantoin (DBDMH). Reaction with piperidine followed by hydrolysis gives the hydroxynorbornanone (IV), which is alkylated with biphenylmethylbromide (B) under phase-transfer catalysis to yield the norbornanone (V). Baeyer-Villiger oxidation followed by partial reduction with diisobutylaluminum hydride (Dibal) gives the aldehyde (VII), which is then homologated to the aldehyde (VIII) using methoxymethylene-phosphorane and subsequent treatment with 2N HCl. Condensation of (VIII) with carboxypropyltriphenylphosphorane in tetrahydrofuran followed by esterification with tritylchloride gives the ester (IX). The alcohol stereochemistry in (IX) is inverted via oxidation with pyridine-sulfur trioxide complex in dimethylsulfoxide followed by reduction with Dibal in the presence of 2,6-di-tert-butyl-4-methylphenol. Finally, the ester is hydrolyzed with hydrochloric acid to give the required acid.
【1】 Coleman, M.J.; et al.; Baeyer-villiger oxidation of 5-endo-(biphenyl-4-ylmethoxy)-7-anti-piperidinobicyclo[2.2.1] process development and scale-Up. Org Process Res Dev 1997, 1, 1, 20. |
【2】 Lumley, P.; Finch, H.; Collington, E.W.C.; Humphrey, P.P.A.; VAPIPROST HYDROCHLORIDE < Rec INNM; BAN >. Drugs Fut 1990, 15, 11, 1087. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
37404 | (3-carboxypropyl)(triphenyl)phosphonium bromide | 17857-14-6 | C22H22BrO2P | 详情 | 详情 | |
(A) | 15148 | 1-phenylethylamine; DL-a-methylbenzylamine; 1-phenyl-1-ethanamine | 618-36-0 | C8H11N | 详情 | 详情 |
(I), (II) | 24421 | (1S,5R)bicyclo[3.2.0]hept-2-en-6-one | C7H8O | 详情 | 详情 | |
(B) | 31210 | 4-(bromomethyl)-1,1'-biphenyl | 2567-29-5 | C13H11Br | 详情 | 详情 |
(III) | 31208 | (1R,2S,3S,5R)-2-bromo-6-oxobicyclo[3.2.0]hept-3-yl acetate | C9H11BrO3 | 详情 | 详情 | |
(IV) | 31209 | 5-hydroxy-7-(1-piperidinyl)bicyclo[2.2.1]heptan-2-one | C12H19NO2 | 详情 | 详情 | |
(V) | 31211 | 5-([1,1'-biphenyl]-4-ylmethoxy)-7-(1-piperidinyl)bicyclo[2.2.1]heptan-2-one | C25H29NO2 | 详情 | 详情 | |
(VI) | 31212 | 6-([1,1'-biphenyl]-4-ylmethoxy)-8-(1-piperidinyl)-2-oxabicyclo[3.2.1]octan-3-one | C25H29NO3 | 详情 | 详情 | |
(VII) | 31213 | 2-[(1R,2R,3R,5S)-5-([1,1'-biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]acetaldehyde | C25H31NO3 | 详情 | 详情 | |
(VIII) | 31214 | 3-[(1R,2R,3R,5S)-5-([1,1'-biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]propanal | C26H33NO3 | 详情 | 详情 | |
(IX) | 31215 | trityl (Z)-7-[(1R,2R,3R,5S)-5-([1,1'-biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoate | C49H53NO4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(-)-(I)Synthesis of the tricyclic ketone intermediate (VI): Optical resolution of racemic bicyclo[3.2.0]hept-2-en-6-one (I) by reaction with SO2 and (+)-a-methylbenzylamine (II) yields a mixture of diastereomeric salts of the a-hydroxysulfonic acid with the chiral amine (II), which are separated by crystallization. Treatment of the purified salt (III) with aqueous Na2CO3 results in the pure enantiomer ()-(I). Reaction of ()-(I) with 1,3-dibromo-5,5-dimethylhydantoin (DBDMH) in acetone/water affords the bromohydrin (IV), which is treated with TBDMS-Cl and imidazole to provide the silyl ether (V). Finally, reaction of the protected bromohydrin (V) with potassium tert-butoxide in toluene gives the target tricyclic ketone intermediate (VI).
【1】 Boulton, L.T.; Brick, D.; Fox, M.E.; et al.; Synthesis of the potent antiglaucoma agent, travoprost. Org Process Res Dev 2002, 6, 2, 138. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(-)-(I) | 24421 | (1S,5R)bicyclo[3.2.0]hept-2-en-6-one | C7H8O | 详情 | 详情 | |
(rac)-(I) | 53261 | bicyclo[3.2.0]hept-2-en-6-one | 13173-09-6 | C7H8O | 详情 | 详情 |
(II) | 10039 | (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine | 3886-69-9 | C8H11N | 详情 | 详情 |
(III) | 53267 | Butanoic acid; Butyric acid; N-Butanic acid; N-Butanoic acid; n-Butyric acid; N-Ethylacetic acid; N-Propanecarboxylic acid; N-Propylformic acid | 107-92-6 | C4H8O2 | 详情 | 详情 |
(IV) | 53258 | (1R,2S,3S,5R)-2-bromo-3-hydroxybicyclo[3.2.0]heptan-6-one | n/a | C7H9BrO2 | 详情 | 详情 |
(V) | 53259 | (1R,2S,3S,5R)-2-bromo-3-{[tert-butyl(dimethyl)silyl]oxy}bicyclo[3.2.0]heptan-6-one | n/a | C13H23BrO2Si | 详情 | 详情 |
(VI) | 53260 | (1R,3S,5R)-3-{[tert-butyl(dimethyl)silyl]oxy}tricyclo[3.2.0.0~2,7~]heptan-6-one | n/a | C13H22O2Si | 详情 | 详情 |